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The RNA-binding proteomes from yeast to man
harbour conserved enigmRBPs
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RNA-binding proteins (RBPs) exert a broad range of biological functions. To explore the scope
of RBPs across eukaryotic evolution, we determined the in vivo RBP repertoire of the yeast
Saccharomyces cerevisiae and identified 678 RBPs from yeast and additionally 729 RBPs from
human hepatocytic HuH-7 cells. Combined analyses of these and recently published data sets
define the core RBP repertoire conserved from yeast to man. Conserved RBPs harbour defined
repetitive motifs within disordered regions, which display striking evolutionary expansion.
Only 60% of yeast and 73% of the human RBPs have functions assigned to RNA biology or
structural motifs known to convey RNA binding, and many intensively studied proteins
surprisingly emerge as RBPs (termed ‘enigmRBPs’), including almost all glycolytic enzymes,
pointing to emerging connections between gene regulation and metabolism. Analyses of
the mitochondrial hydroxysteroid dehydrogenase (HSD17B10) uncover the RNA-binding
specificity of an enigmRBP.
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R
NA-binding proteins (RBPs) mediate pivotal cellular
functions such as RNA transport, degradation or transla-
tion and represent key effectors of post-transcriptional gene
regulation. To fulfil such diverse roles, RBPs vary regarding their
RNA-binding modes and specificities1. Recently developed
unbiased high content techniques to identify RBPs in vivo
yielded information on differences in cell type-specific expression
and/or RNA-binding activity of RBPs in mammalian cells2,3.
Apart from RBPs with defined functions4 in RNA biology, many
other proteins, among them metabolic enzymes, have been found
to bind RNA in vivo5. The recent discovery of such unorthodox
RBPs using mRNA interactome capture2,3,6 raises the question of
the evolutionary conservation and the RNA-binding specificity
of such RBPs. To answer the first question, we determined the
mRNA interactomes of the yeast Saccharomyces. cerevisiae
(S. cerevisiae) (BY4741) and of human hepatocytic cells (HuH-7).
To address the second, we investigated RNAs bound by the
metabolic enzyme hydroxysteroid dehydrogenase 17-b 10
(HSD17B10). Here we identify a large set of RBPs that are
conserved between yeast and human cells. We show that this
conserved RNA interactome harbours many proteins without
previously assigned roles in RNA biology (enigmRBPs), including
surprisingly many metabolic enzymes. We also determined the
RNA targets of an RNA-binding mitochondrial enzyme and show
its specificity in RNA binding.
Results
The mRNA interactomes of yeast and human HuH-7 cells.
HuH-7 liver cells were exposed to ultraviolet light of 254 nm
(conventional crosslinking, cCL), or of 365 nm (photo-activatable
crosslinking, PAR-CL) after incubation with 4-thio-uridine7.
We also adapted the mRNA interactome capture protocol to
yeast (see Methods and Supplementary Fig. 1) using PAR-CL at
0.72 or 7.2 J cm 2 (ref. 8) with 4-thio-uracil. After cell lysis,
polyadenylated RNAs were captured on oligo d(T) beads followed
by stringent washes to remove non-crosslinked proteins. The cCL
and PAR-CL samples, along with non-crosslinked controls (noCL
and analogs only, respectively), were analysed by LC-MS/MS2
(Fig. 1a).
The yeast RBPs, KHD1 and PUB1, serving as positive controls,
show dose-dependent enrichment, whereas highly abundant
cellular proteins (tubulin, histones) used as specificity controls
are negative (Fig. 1a, upper right panel). Similarly, the established
mammalian RBPs PTBP1 and CSDE1 are specifically enriched in
eluates from crosslinked HuH-7 samples (Fig. 1a, lower right).
Using three biological replicates and applying stringent statistical
tests (see Methods), we identify 678 (yeast) and 729 (HuH-7)
high-confidence RBPs (false discovery rate (FDR) 0.01) (Fig. 1b,c;
Supplementary Fig. 2; Supplementary Data 1 and 2). An
additional 135 candidate RBPs are detected from HuH-7 cells
at FDR 0.05 (Supplementary Data 2).
Validation experiments corroborate the quality of the data sets
(Fig. 1d,e). Comparison of the HuH-7 RBPs with the HeLa and
HEK293 data sets begins to define a ‘housekeeping’ human
mRNA interactome, while 109 HuH-7 RBPs were previously not
found in other human cell types (Fig. 1f; Supplementary Data 2).
The latter may be explained by cell-specific expression or culture
condition-dependent RNA binding of RBPs. Our data confirm
108 of the 120 yeast RBP candidates from a recent study9.
Importantly, we identify 570 additional yeast proteins as high-
confidence RBPs (Fig. 1g; Supplementary Data 1), and an
astounding 410% of the total yeast proteome thus emerge as
RBPs10 (see below).
Definition of the conserved eukaryotic mRNA interactome.
These sets of yeast and human RBPs were analysed for RBP
conservation. Comparison of yeast with each of the three human
cell lines consistently yields an overlap of 4200 orthologous
RBPs (Fig. 2a). We used the InParanoid database that assigns
RBPs to ‘ortholog groups’ of corresponding biological functions
(Methods). Two-hundred and thirty ortholog groups consisting
of 243 individual RBPs in yeast and 256 RBPs in human (Fig. 2b;
Supplementary Data 1 and 2) constitute the conserved eukaryotic
‘core mRNA interactome’. As expected, it includes many well-
studied RBPs with established functions in RNA biology and/or
with well-defined RNA-binding domains (Supplementary
Fig. 3a,b). Interestingly, some ‘core RBPs’ share lysine [K]- and
arginine [R]-rich tripeptide repeat motifs that numerically
increase from yeast to human (Fig. 2c,d). Whereas their general
occurrence is conserved, their number within orthologous RBPs
expands with increasing complexity of the organisms. These
expansions may directly interact with RNA and represent an
emerging structural property of nucleic acid interactors11–13,
possibly to enhance RNA-binding specificity within increasingly
complex transcriptomes. The RBPs eIF3a and THOC2 are
depicted as examples in Fig. 2e.
Well-studied proteins emerge as conserved enigmRBPs.
Merging our data sets with published information on yeast9
(690 RBPs in total, Supplementary Data 1) and human RBPs2,3
(1,217 RBPs in total, Supplementary Table 2), we were surprised
to find that 40% (274 yeast proteins) and 27% (326 human
proteins), respectively, of the identified RBPs lack both
recognizable RBDs and known functions in RNA biology
(selection criteria see Methods). These RBPs include many
well-studied proteins whose roles in RNA biology remain
to be defined (Fig. 3a); we therefore termed these proteins
‘enigmRBPs’. Phosphoglycerate kinase and thioredoxin14,15
represent enigmRBPs that we directly validated for RNA
binding both in human and yeast cells (Fig. 1d,e and Castello
et al., submitted). enigmRBPs cover a wide spectrum of biological
Figure 1 | mRNA interactome capture in yeast and HuH-7 cells. (a) Schematic representation of the mRNA interactome capture protocol in yeast and
HuH-7 cells using PAR crosslinking (PAR-CL) or conventional crosslinking (cCL). Quality controls for both yeast and HuH-7 include silver staining (middle
upper and lower panel) and western blotting (right upper and lower panel) (M, protein marker, KHD1, KH-domain containing protein1 fused to eGFP, PUB1,
polyU binding protein 1, TUB1, tubulin 1, H4, histone 4, PTBP1, polypyrimidine tract binding protein 1, CSDE1, cold shock domain containing protein E1).
(b) Volcano plot showing the distribution of proteins according to their enrichment in crosslinked (CL) over non-CL samples. Proteins shown in red (FDR
0.01) represent the mRNA interactome. (c) Overlap of mRNA interactome proteins in yeast and HuH-7. (d) Validation of the yeast mRNA interactome
using western blotting of input samples and eluate after interactome capture with specific antibodies (ADH1, alcohol dehydrogenase 1, PUB1) or against
TAP-tagged proteins (PGK1, phosphoglycerate kinase 1, TDH1, triose phosphate dehydrogenase, TRX2, thioredoxine 2, SHE2, Swi5p-dependent HO
Expression 2). (e) Validation of HuH-7 mRNA interactome RBPs using polynucleotide kinase-mediated 32P labelling after IP with an anti-eGFP antibody
(negative control eGFP and MRPP3, mitochondrial RNAseP protein 3; positive control MOV10, moloney leukaemia virus 10; and novel RBPs, HSD17B10,
hydroxysteroid dehydrogenase 17B 10, c11orf68, chromosome 11 open reading frame 68, CRKL, v-crk avian sarcoma virus CT10 oncogene homologue-like,
LLPH, long-term synaptic facilitation homolog, PGK1, phosphoglycerate kinase 1). (f) Comparison of mRNA interactome RBPs from HuH-7 with those from
HeLa and HEK293 cells. (g) Comparison of the yeast mRNA interactome RBPs to a published study using cCL9.
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functions, including, for example, actin-binding/remodelling,
protein folding, ATP-binding and enzymatic functions in classic
metabolic pathways (Supplementary Table 1). enigmRBPs
resemble orthodox RBPs in terms of typical features
(Supplementary Fig. 3c,d) in both yeast and human cells, and
constitute a surprisingly large fraction of the conserved core RBPs
(42 (17%) yeast and 28 (11%) human RBPs). A few enzymes of
classical biochemical pathways that moonlight as RBPs have
previously been identified16–18. We thus searched the complete
yeast and human RBP data sets (including the HuH-7 candidate
RBPs) for ‘classic’ metabolic enzymes (hereafter referred to as
enzymes; for selection criteria see Methods). Yeast RBPs (17%)
and 9% of the human RBPs belong to this group (Fig. 3b;
Supplementary Data 1 and 2); transferases and oxidoreductases
constitute more than half of these (Supplementary Fig. 3e).
Strikingly, 9% of the conserved core RBPs are metabolic enzymes
(Fig. 3c; Supplementary Fig. 3f), and central carbon metabolism,
especially glycolysis, emerges as a hotspot for RNA-binding
enzymes (Fig. 3d,e).
RNA binding of a mitochondrial enzyme. To explore the
binding specificity of metabolic enzymes for RNA, we performed
iCLIP19 and determined the interacting RNAs of the
mitochondrial enzyme HSD17B10, which is mutated in patients
with a mitochondrial cardiomyopathy/neuropathy syndrome
(OMIM 300438), and for which a non-enzymatic function has
been suspected to account for the disease phenotype20.
HSD17B10 has been described as a subunit of the RNase
P complex21 (together with TRMT10C and MRPP3) that
processes mitochondrial tRNAs, which are interspersed within
polycistronic mitochondrial transcripts22. Of note, MRPP3 did
not appear in any of the human mRNA interactome data sets, nor
could we detect ultraviolet-crosslinked RNAs on the protein
(Fig. 1e). Thus, the RNA binding presumably resides on
TRMT10C (RNA methyltransferase), the tetrameric HSD17B10
(dehydrogenase) or the complex of these two23. We observed
enriched binding of HSD17B10 to mitochondrial RNAs
(Supplementary Fig. 4a,b), and compared the RNA-protein
crosslink sites of wt HSD17B10 to an eGFP background control
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(Fig. 4a–c). We found that HSD17B10 preferentially binds at the
50ends of tRNAs (Fig. 4d), especially their D-stem, D-loop and
anticodon stem and loop regions, on 15 out of 22 mt tRNAs
(Supplementary Fig. 5); suggesting that the mitochondrial
RNAse P does not mediate processing of all tRNAs. Indeed,
processing of tRNAs that are encoded in clusters (tRNAHis,
tRNASer(AGY), tRNALeu(CUN), Supplementary Fig. 5) was
suggested to be mediated by the combination of RNAse P and
the ELAC2 complex, which processes 30 end of mt tRNAs24. Next,
we performed iCLIP on the disease-associated variant, HSD17B10
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R130C, that causes the classical phenotype of HSD10 disease20,
retains the ability for tetramerization and displays a reduced
interaction with TRMT10C in vitro25. Of note, the R130C variant
exhibits a decreased binding signal to several pre-tRNAs (Fig. 4f;
Supplementary Data 4). Our data identify the mitochondrial
enzyme HSD17B10 as the RNA-binding subunit of RNaseP
in vivo, and reveals that the R130C mutant is deficient in binding
of a subset of pre-tRNAs. They also identify an RBP from the
dehydrogenase enzyme family with clear RNA-binding specificity.
Discussion
Taken together, the data identify a surprisingly high number
of RBPs in yeast and humans, including many previously
well-characterized proteins that emerge to have conserved
RNA-binding activity in vivo (enigmRBPs). Although in vivo
RNA binding does not prove physiological function per se, we
note that the enzyme b-hydroxysteroid dehydrogenase displays
remarkable RNA-binding specificity (Fig. 4). Moreover, the two
enzymes aconitase 1 (ref. 18) and GAPDH16 are known to
function as regulatory RNA-binding proteins in vivo, suggesting
that other enigmRBPs may also moonlight as post-transcriptional
regulators5. Alternatively, RNAs could regulate enigmRBPs: by
competition with substrates for binding sites within enzymes, as
allosteric regulators, or as assembly scaffolds for alignment of
enzymes in a biochemical pathway26,27. RNA binding could also
influence the folding, assembly or fate of newly synthesized
proteins emerging from the ribosome, especially considering the
fact that lysine and arginine-rich sequences have a propensity to
induce ribosome stalling and protein degradation28,29. The innate
immune effectors PKR, TLR3, TLR7, TLR8 and RIG-I are
controlled by pathogen-derived RNAs30,31. We propose that
endogenous ‘effectorRNAs’ could serve roles akin to protein–
protein interactors for enigmRBPs, and endow the genome with
the possibility to affect mature proteins.
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Methods
Yeast cultures. Yeast colonies (BY4741, TAP-tagged strains) were used to
inoculate a 5ml YPAD pre-culture overnight at 30 C and 160 r.p.m. The next day,
1 litre SC-medium120mM Ura (YNB, SD-URA, 120 mM Ura, 1% glucose) cultures
were started with an OD600 of 0.01–0.05.
HuH-7 cell culture. Cells (kind gift from M. Muckenthaler, MMPU, Heidelberg)
were cultured in low glucose (5mM) DMEM supplemented with 10% heat
inactivated FCS (PAA). For the validation procedures, we derived a HuH-7 Flp-In
TREx cell line using published protocols (Flp-In T-Rex, Life), and prepared stably
expressing tetracycline-inducible cell lines with genes of interest following
manufacturer’s instructions. The cells were grown in medium containing
blasticidine (5mgml 1) and zeocin (100 mgml 1) or hygromycine (200 mgml 1).
Transfections were done using Lipofectamine (18324-012, Life).
Cloning. Human genes of interest were cloned into pcDNA5_FRT_TO (Life). The
detailed cloning strategies and primer sequences are described in Supplementary
Table 2.
mRNA interactome capture. For HuH-7 cells, experiments were done with minor
modifications in the cell lysis procedure to previously described procedure7. The
cells were washed twice with PBS on ice before ultraviolet crosslinking. After
crosslinking, the cells were lysed directly with lysis buffer on the cell culture plates,
scraped and collected into 50ml tubes. Lysates were sheared through 27G needle
and incubated with oligo d(T) beads (volume ratio lysate to beads 15:1) for 1 h at
4 C. Beads were then washed twice with each wash buffer and pooled elutions
from three rounds of purifications were used for RNase treatment and subsequent
processing for mass spectrometry.
For yeast mRNA interactome capture, cells were grown as described above
to an OD600 of 0.5 before adding 4-thiouracil (4tU, Sigma 440736) to a final
concentration of 500 mM. Cells were allowed to grow for 3 h before harvesting by
centrifugation (4,000 r.p.m.; 15min; 4 C). The cell pellet was dissolved in 40ml
cold water and spread onto two Petri dishes. Ultraviolet crosslinking was
performed on ice in a Spectrolinker device (Spectronics, XL1500F/A) emitting
Ultraviolet light at 365 nm wavelength using energies from 0.72 to 7.2 J cm 2. Cells
were re-pelleted (4,000 r.p.m.; 5min; 4 C), and pellets were dissolved in 2ml lysis
buffer (20mM Tris pH 7.5, 500mM LiCl, 0.5% LiDS, 1mM EDTA, 5mM
dithiothreitol (DTT), 1 protease inhibitor mix (EDTA-free, Roche), 1mgml 1
RNasin, 200mM VRC). Cells were distributed into 2ml screw-capped tubes
containing an equivalent of 300 ml acid-washed glass beads, and lysed in a FastPrep
device (MP bio; 6m s 1; 5 60 s bursts with 20 s pausing in between). The lysate
was cleared by centrifugation (12,000 r.p.m.; 2min; 4 C) and the supernatant was
transferred to a 50-ml tube before snap-freezing in liquid nitrogen and storage at
 80 C. After adding lysis buffer to 25ml, the remaining protocol was performed
as described7 using 1ml oligo d(T) beads per litre of starting culture. Elutions from
two rounds of purification were pooled before downstream processing.
Notes on in vivo labelling and crosslinking. Note that for Photoactivatable-
Ribonucleoside-Enhanced Crosslinking (PAR-CL) we used 4-thiouracil (4tU)
for yeast and 4-thiouridine (4SU) for HuH-7 cells, respectively. Conventional
crosslinking (cCL) in yeast did not yield satisfactory results, because titration
experiments using UV254 dosages of 0.04–1.2 J cm 2 revealed either insufficient
RBP crosslinking, or the integrity of total RNA and RNA after oligo-d(T) selection
(see above) using an RNA Pico Chip (Agilent BioAnalyzer 2100) was found to be
compromised (as indicated by the decrease of the ribosomal RNA peaks) already
after limited irradiation with ultraviolet light at 254 nm (Supplementary Fig. 1).
This UV254-induced RNA damage represents the likely cause of low RBP recovery
by the cCL protocol, which was hence not pursued further.
Peptide stable isotope labelling and fractionation. Recovered proteins were
digested using a combination of the endoproteinases Lys-C and trypsin, as
described in detail before3,4. Protein digests were dimethyl labelled on column as
previously described with slight modifications32. Briefly, SepPak C18 cartridges
(Waters) were washed with acetonitrile (AcN) and conditioned with 0.1% (v/v)
formic acid. Acidified samples were loaded and washed with 0.1% formic acid.
Samples were labelled by flushing the columns with labelling reagent (using CH2O
(Fisher)þNaBH3CN (Fluka) or CD2O (Isotec)þNaBH3CN). After washing with
0.1% formic acid, labelled peptides were eluted with 80% (v/v) AcN/0.05% (v/v)
formic acid. Samples were mixed in a 1:1 ratio based on the total peptide amount,
determined by analysing an aliquot of the labelled samples on regular LC-MS runs
and comparing overall peptide signal intensities. Samples were dried by vacuum
centrifugation, reconstituted in IPG rehydration buffer (8M urea, 0.4% DTT, 1%
CHAPS, 2.5% Pharmalyte) and fractionated according to manufacturer’s
instructions using pH 3–10 IPG strips and 3100 OFFGEL fractionator (Agilent).
The 12 fractions resolved were acidified and desalted with C18 Stagetips (Empore
3M)33. Peptide samples were dried by vacuum centrifugation and stored at  20 C
until further use.
LC-ESI-MS/MS analysis. Peptide samples were analysed by LC-MS/MS
as described in detail before2,7. In brief, peptides were separated using a
nanoACQUITY UPLC system (Waters) fitted with a trapping column
(nanoAcquity Symmetry C18, 5 mm, 180 mm 20mm) and an analytical column
(nanoAcquity BEH C18, 1.7 mm, 75mm 200mm). Peptides were resolved in a
gradient of AcN in 0.1% (v/v) formic acid, increasing the percentage of AcN from 3
to 7% in 10min, then to 25% in 100min and finally to 40% in a further 10min.
Eluting peptides were analysed by direct coupling to an OrbitrapVelos Pro
(Thermo Fisher Scientific) using a Proxeon nanospray source. Full scan spectra
from m/z 300 to 1,700 at resolution 30,000 (profile mode) were acquired in the
Orbitrap. The filling time was set at a maximum of 500ms with limitation of 10E6
ions. The most intense ions (up to 15) carrying multiple charges (2þ and 3þ )
were selected for fragmentation in the ion trap. Normalized collision energy of 40%
was used, and fragmentation was performed after accumulation of 3 10E4 ions or
after filling time of 100ms for each precursor ion (whichever occurred first).
Dynamic exclusion of 30 s was applied.
Protein identification and quantification. MS raw data files were processed with
MaxQuant (version 1.2.2.5)34. Enzyme specificity was set to trypsin/P and a
maximum of two missed cleavages were allowed. Cysteine carbamidomethylation
and methionine oxidation were selected as fixed and variable modifications,
respectively. The derived peak list was searched using the built-in Andromeda
search engine (version 1.2.2.5) in MaxQuant against the Uniprot human database
(2013_03) or S. cerevisiae database (2013_01), respectively, to which 248 frequently
observed contaminants as well as reversed sequences of all entries had been added.
Initial maximal allowed mass tolerance was set to 20 p.p.m. for peptide masses,
followed by 6 p.p.m. in the main search, and 0.5Da for fragment ion masses. The
minimum peptide length was set to six amino-acid residues, and three labelled
amino-acid residues were allowed. A 1% FDR was required at both the protein level
and the peptide level. In addition to the FDR threshold, proteins were considered
identified if they had at least one unique peptide. Peptide identifications were
transferred between matching runs, based on the retention time (2min window)
and the accurate peptide masses determined in the Orbitrap analyzer. Protein
identification was reported as an indistinguishable ‘protein group’ if no unique
peptide sequence to a single database entry was identified. Protein quantification
was based on unique and razor peptides.
Definition of mRNA interactome proteins. Peptide UniProt accession numbers
were converted into ENSEMBL gene IDs. Where multiple ENSEMBL gene
IDs applied, the peptide group was not considered. Statistical analysis was
performed using an empirical Bayes moderated t-test within the Limma package in
R/Bioconductor35. P values were adjusted for multiple testing using the method of
Benjamini and Hochberg. Proteins within FDR 1% were considered as mRNA
interactome proteins.
SDS–PAGE, western blotting and silver staining. The procedures were
performed according to the standard protocols. Antibodies used were anti-eGFP
(1:3,000, 3H9, Chromotek), PUB1 (1:3,000, kind gift from Maurice Swanson),
tubulin (1:3,000, ab6161, Abcam), histone H4 (1:1,000, 2592, Cell Signaling),
PTBP1 (1:1,000, 5725M1, Sigma), b-actin (1:2,000, A5441, Sigma) and CSDE1
(1:2,000, 13319-1-AP, PTG). The TAP-tagged yeast proteins were visualized by
staining with anti-rabbit secondary antibodies conjugated to HRP (1:10,000,
NA934V, GE). Uncropped blots are shown in the Supplementary Fig. 6.
Polynucleotide kinase assay. Cells expressing tagged genes of interest were
ultraviolet crosslinked, lysed (100mM KCL, 5mM MgCl2, 10mM Tris pH 7.5,
0.5% NP40, 1mM DTT, protease inhibitors) and homogenized with ultrasound
(3 10 s, 50% amplitude) on ice. Cleared lysates were treated with 50Uml 1
DNAseI (Takara) and 8 ng ml 1 RNase A (Sigma) for 15min at 37 C, and used for
immunoprecipitation with anti-eGFP coupled to magnetic beads (Chromotek) for
2 h at 4 C. Beads were washed 4 with washing buffer (500mM NaCl, 20mM
Tris pH 7.5, 1mM MgCl2, 0.05% NP40, protease inhibitors) and 2 with poly-
nucleotide kinase (PNK) buffer (50mM Tris pH 7.5, 50mM NaCl, 10mM MgCl2,
0.5% NP40, 5mM DTT). Beads were resuspended in PNK buffer with 0.1 mCi ml 1
[g-32 P]rATP (Hartmann) and 1U ml 1 T4 PNK (NEB) and labelled for 15min at
37 C. After five washes with PNK buffer without DTT, beads were boiled and
loaded onto SDS–PAGE gels. The blot was then autoradiography exposed.
IP efficiency was controlled by anti-eGFP antibody (1:3,000, 3H9, Chromotek).
Uncropped blots and phosphorimages are shown in the Supplementary Fig. 6.
RBPs classifications. We used the Gene Ontology (GO) database to curate the
protein list (ENSEMBL gene identifiers). We assigned proteins as ‘linked mRNA
biology’ if their associated GO terms contained at least one of the following terms:
 ‘mRNA’
 ‘splic’
 ‘RNA binding’
 ‘RNA’
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 ‘RNP’
 ‘translation’
 ‘ribosom’
 ‘nuclease’
 ‘exosome’
Some of the above terms were shortened from original words on purpose to
capture multiple variations of these. If the protein did not fall in this category,
we assigned it as ‘unknown’ in RNA biology. Domain classification based on
Interpro and Pfam domains was described in ref. 2. We devised new category for
RBD domains ‘recognized’ that encompasses both ‘classical’ and ‘non-classical’
categories from ref. 2.
Complete human mRNA interactome data set. For the complete human mRNA
interactome data set, we used the combination of proteins found in this study
(FDR 1%), proteins from HeLa mRNA interactome2 and HEK293 cell
RNA-binding proteins (Supplementary Data 1)3.
Complete yeast mRNA interactome data set. For the complete yeast mRNA
interactome data set, we combined the proteins of this study (FDR 1%) and the
proteins from ref. 9.
Disordered regions and low complexity. The intrinsic disorder of proteins is
computed with IUPred36. Disordered amino-acid residues are defined by a IUPred
score of 40.4. For each protein, the fraction of disordered amino-acid residues is
computed. To assess complexity, shannon entropy is computed for each amino
acid position within a window of±10 residues. Positions with an entropyo3 bits
are considered as low complexity. For each protein, the fraction of amino-acid
residues in low-complexity regions is computed.
Ortholog definition. To define orthologs of yeast and human, ENSEMBL gene
ID were converted to UniProt IDs and used for the InParanoid ortholog groups
database (Release 7.0, June 2009)37. There were 2,041 InParanoid ortholog groups
in total, covering 3,670 human and 2,386 yeast proteins. InParanoid clusters were
categorized according to their mRNA-binding behaviour. An InParanoid cluster
was regarded as mRNA binding, if at least one of the contained proteins is included
in the complete human or yeast mRNA interactome data set. This categorization
resulted in three groups of InParanoid clusters: some showed mRNA binding in
human and yeast, some showed mRNA binding only in human and some did not
show mRNA binding either in yeast or in human. There was not a single
InParanoid cluster that shows mRNA binding in yeast, but not in human.
K-mers motif evolution across species. The InParanoid database was used to
find clusters from Caenorhabditis elegans (C. elegans), Drosophila melanogaster
(D. melanogaster) and Danio rerio (D. rerio), which contain orthologs to the 2,041
ortholog groups described above. Within each InParanoid cluster, the protein with
the longest (isoform) sequence was chosen as the representative for the cluster. For
each yeast–human orthology group, one orthologous protein in fish (respectively,
fly and worm) was selected. Selection was based on orthology to the representative
protein in yeast and the representative protein in human. If there were multiple
proteins that fulfilled the previous condition, the protein with the largest number
of amino acids was chosen. A list of K-mers was computed for each organism,
providing a vector of K-mers for each protein in each organism. Next, we created a
list of all K-mers appearing in the conserved human and yeast proteins; K-mers
containing an ‘X’ or ‘U’ were excluded. A table counting the repeat number of each
motif in each protein was computed for each of the five organisms. The tables were
combined to a three-dimensional array (proteins  motifs  organisms). For
each motif n, we tested if the mRNA-binding proteins were enriched for proteins in
which the copy number of motif n in human was at least increased by two
compared with yeast. The P values were computed by Fisher’s exact test and
P values were corrected for multiple testing by the method of Benjamini–Hochberg.
Motifs at a FDR of 0.2 were selected as ‘increase in repeat numbers’ motifs.
GO enrichments analysis. For GO enrichment analysis, the DAVID database
(version 6.7)38,39 was used. As a background, the total human or yeast proteomes,
respectively, were used.
‘Classic’ metabolic enzymes. We used the IntEnz database (http://www.ebi.ac.uk/
intenz/) to classify all enzymes in the mRNA interactomes. For the purpose of this
study and to exclude obvious RNA-related enzymes, we did not consider the
following as classic metabolic enzymes:
 RNA/DNA helicases
 tRNA, rRNA modification enzymes (tRNA methyltransferase,
pseudouridylases and so on)
 nucleases (RNA or DNA)
 tRNA aminoacylsynthetases
 RNA/DNA polymerases
 topoisomerases
 proteasome subunits
 regulatory subunits (of any enzyme)
iCLIP and data analysis. iCLIP was performed with following modifications.
Stably expressing HuH-7 cells were induced overnight with 100 ngml 1 of
tetracycline, ultraviolet-crosslinked and lysed on plate. Lysates were homogenized
using Branson sonifier (3 10 s, 50% amplitude) and cleared at 13,000 r.p.m. for
10min. IP with anti-GPF magnetic beads was performed as described above and
following washes were applied twice each: high-salt wash (500mM NaCl; 20mM
Tris pH 7.5; 1mM MgCl2; 0.05% NP40; 0.1% SDS), medium-salt wash (250mM
NaCl; 20mM Tris pH 7.5; 1mM MgCl2; 0.05% NP40) and low-salt wash (150mM
NaCl; 20mM Tris pH 7.5; 1mM MgCl2; 0.01% NP40). After RNase treatment and
dephosphorylation of 30 ends, RNA linker was ligated overnight at 850 r.p.m. at
16 C. Beads were treated with proteinase K and eluates were used for RNA
isolation, cDNA production and sequencing following published protocol19.
Low-FDR crosslink sites read values were then used for the DESeq analysis40.
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